Sanofi nets €10B from Opella sale, eyes more 'bolt-on' deals
Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice, Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 billion euros ($11.4 billion).
Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice, Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 billion euros ($11.4 billion).
